ANDREAS REVELIS: Open Payments
NPI 1902809080 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$783 in 40 payments from 10 companies in 2025. Trend: 2023 $52 · 2024 $197 · 2025 $783
Food & beverage: $783
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 21 | $401 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $102 |
| Collegium Pharmaceutical, Inc. | 5 | $92 |
| Medtronic, Inc. | 2 | $44 |
| AppliedVR Inc | 2 | $37 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $31 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Saluda Medical Americas, Inc. | 1 | $21 |
| Averitas Pharma Inc. | 1 | $18 |
| Zimmer Biomet Holdings, Inc. | 1 | $14 |
Products named: WaveWriter Alpha Prime 16, RELISTOR, Belbuca, RelieVRx, JOURNAVX, INCEPTIV, Zilretta, Evoke.
Industry payments across OK — which companies pay providers there.
